Morningside Graduate School of Biomedical Sciences at UMass Chan

Morningside Graduate School of Biomedical Sciences at UMass Chan Students and faculty of the Morningside Graduate School of Biomedical Sciences at UMass Chan Medical

The GSBS comprises 400 students and 300 distinguished research faculty who form a diverse and collegial community of scholars hailing from across the United States and around the world. Our students and faculty share a passion for biomedical research and their work is internationally recognized for its impact, quality and breadth. We invite you to explore their research, which spans the study of s

ingle molecules through population genomics and outcomes and to learn more about our school at http://www.umassmed.edu/gsbs/

Weโ€™re moving! For news about PhD students and faculty in the Morningside Graduate School of Biomedical Sciences and admi...
08/01/2022

Weโ€™re moving! For news about PhD students and faculty in the Morningside Graduate School of Biomedical Sciences and admissions deadlines and opportunities, follow UMass Chan Medical School.

Commencement is this weekend ๐ŸŽ‰๐ŸŽ‰ We can't wait to see you there!
06/01/2022

Commencement is this weekend ๐ŸŽ‰๐ŸŽ‰ We can't wait to see you there!

UMass Chan Medical School will celebrate the accomplishments of the Class of 2022 at a series of events leading up to the 49th Annual Commencement Exercises on Sunday, June 5.

03/18/2022

An international team of investigators has discovered that an inorganic polyphosphate released by nerve cells known as astrocytes in people with ALS and frontotemporal dementia contributes to the motor neuron death that is the signature of these diseases.

Dan and Diane Riccio, two UMass alumni, have pledged $15 million to UMass Chan Medical School to support advances in neu...
02/11/2022

Dan and Diane Riccio, two UMass alumni, have pledged $15 million to UMass Chan Medical School to support advances in neuroscience research.

This gift is the third and largest donation by the Riccios to UMass Chan, and it includes $10 million for the Riccio ALS Accelerator Initiative and $5 million to expand and endow the Riccio Fund for Neuroscience. https://bit.ly/3LnWmvX

Dr. Katherine Fitzgerald has been named the 2022 recipient of the American Association of Immunologists - Thermo Fisher ...
01/28/2022

Dr. Katherine Fitzgerald has been named the 2022 recipient of the American Association of Immunologists - Thermo Fisher Meritorious Career Award. Congratulations, Dr. Fitzgerald!

The award recognizes a mid-career scientist for outstanding contributions to the field of immunology. Read more on Dr. Fitzgerald's pioneering work and the award: https://bit.ly/3r60ubz

01/25/2022
Dr. Jason Shohet recently received a second Hyundai Hope on Wheels grant to continue his work in overcoming drug resista...
01/13/2022

Dr. Jason Shohet recently received a second Hyundai Hope on Wheels grant to continue his work in overcoming drug resistance in treatments for neuroblastoma.

In the original grant, Shohet and Dr. Joae Qiong Wu found that drugs targeting the enzyme protein methyltransferase 5 (PRMT5) dramatically inhibited tumor growth and tumor metastasis. The new grant will fund work focusing on combining PRMT5 targeting with established treatments.

https://bit.ly/3nmxb2e

In a single-patient pilot study, research by Dr. Robert Brown and Dr. Jonathan Watts has shown the ability to suppress m...
01/06/2022

In a single-patient pilot study, research by Dr. Robert Brown and Dr. Jonathan Watts has shown the ability to suppress mutant forms of an ALS gene known as C9ORF72. โ€œThe results are very encouraging. It means this is a viable approach to suppressing the mutant C9ORF72 protein that causes most cases of familial ALS," said Dr. Brown

Robert H. Brown Jr., DPhil, MD, Jonathan Watts, PhD, and colleagues have shown the ability to suppress mutant forms of an ALS gene in a single-patient pilot study.

12/21/2021

2021 was a busy year for UMass Chan! Watch to remember these landmark moments.

12/14/2021

Brian Lewis, PhD, is studying therapeutic resistance in pancreatic cancer cells, hoping to change the grim statistics for patients diagnosed with pancreatic cancer.

11/30/2021

Address

55 Lake Avenue N
Worcester, MA
01655

Alerts

Be the first to know and let us send you an email when Morningside Graduate School of Biomedical Sciences at UMass Chan posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The University

Send a message to Morningside Graduate School of Biomedical Sciences at UMass Chan:

Share